iNtRON Biotechnology Statistics

Total Valuation

iNtRON Biotechnology has a market cap or net worth of KRW 176.36 billion. The enterprise value is 122.41 billion.

Market Cap	176.36B
Enterprise Value	122.41B

Important Dates

The next estimated earnings date is Monday, February 17, 2025.

Earnings Date	Feb 17, 2025
Ex-Dividend Date	Dec 27, 2024

Share Statistics

iNtRON Biotechnology has 32.72 million shares outstanding. The number of shares has decreased by -0.63% in one year.

Current Share Class	n/a
Shares Outstanding	32.72M
Shares Change (YoY)	-0.63%
Shares Change (QoQ)	+0.41%
Owned by Insiders (%)	16.61%
Owned by Institutions (%)	4.20%
Float	27.28M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	20.70
PB Ratio	1.97
P/TBV Ratio	2.00
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	-25.42
EV / Sales	14.21
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	-20.43

Financial Position

The company has a current ratio of 51.05, with a Debt / Equity ratio of 0.00.

Current Ratio	51.05
Quick Ratio	49.67
Debt / Equity	0.00
Debt / EBITDA	n/a
Debt / FCF	-0.07
Interest Coverage	-176.65

Financial Efficiency

Return on equity (ROE) is -5.16% and return on invested capital (ROIC) is -2.70%.

Return on Equity (ROE)	-5.16%
Return on Assets (ROA)	-2.66%
Return on Capital (ROIC)	-2.70%
Revenue Per Employee	113.35M
Profits Per Employee	-63.36M
Employee Count	76
Asset Turnover	0.09
Inventory Turnover	2.74

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -38.31% in the last 52 weeks.

Beta (5Y)	n/a
52-Week Price Change	-38.31%
50-Day Moving Average	5,671.40
200-Day Moving Average	6,279.75
Relative Strength Index (RSI)	46.93
Average Volume (20 Days)	131,688

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, iNtRON Biotechnology had revenue of KRW 8.61 billion and -4.82 billion in losses. Loss per share was -145.53.

Revenue	8.61B
Gross Profit	5.53B
Operating Income	-4.05B
Pretax Income	-3.97B
Net Income	-4.82B
EBITDA	-1.99B
EBIT	-4.05B
Loss Per Share	-145.53

Full Income Statement

Balance Sheet

The company has 54.38 billion in cash and 421.05 million in debt, giving a net cash position of 53.96 billion or 1,649.01 per share.

Cash & Cash Equivalents	54.38B
Total Debt	421.05M
Net Cash	53.96B
Net Cash Per Share	1,649.01
Equity (Book Value)	89.37B
Book Value Per Share	2,731.33
Working Capital	55.93B

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 698.94 million and capital expenditures -6.69 billion, giving a free cash flow of -5.99 billion.

Operating Cash Flow	698.94M
Capital Expenditures	-6.69B
Free Cash Flow	-5.99B
FCF Per Share	-183.14

Full Cash Flow Statement

Margins

Gross margin is 64.24%, with operating and profit margins of -47.02% and -55.90%.

Gross Margin	64.24%
Operating Margin	-47.02%
Pretax Margin	-46.05%
Profit Margin	-55.90%
EBITDA Margin	-23.14%
EBIT Margin	-47.02%
FCF Margin	n/a

Dividends & Yields

This stock pays an annual dividend of 100.00, which amounts to a dividend yield of 1.86%.

Dividend Per Share	100.00
Dividend Yield	1.86%
Dividend Growth (YoY)	n/a
Years of Dividend Growth	1
Payout Ratio	n/a
Buyback Yield	0.63%
Shareholder Yield	2.49%
Earnings Yield	-2.70%
FCF Yield	-3.40%

Dividend Details

Stock Splits

The last stock split was on January 10, 2019. It was a forward split with a ratio of 2.

Last Split Date	Jan 10, 2019
Split Type	Forward
Split Ratio	2

Scores

iNtRON Biotechnology has an Altman Z-Score of 88.07.

Altman Z-Score	88.07
Piotroski F-Score	n/a